Vatter, H
The so-called obesity epidemic harms people living in larger bodies, contributes to anti-fatness and body weight bias, and can lead to mental health problems and eating disorders, such as binge eating disorder, anorexia nervosa, or bulimia nervosa
In the SURPASS-2 diabetes trial, an open-label 40-week study randomised 1,879 patients with type 2 diabetes to tirzepatide 5, 10, or 15 mg or to semaglutide 1 mg
Ung sai liu lng v thi im u l nguyn nhn khin bn kh t c kt qu lm p nh mong i
Laboratory-accreditation signals such as ISO/IEC 17025 for the testing lab and cGMP for the manufacturer were treated as strong positives
For the best results, never increase your dose on your own